Faculty Opinions recommendation of Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Keyword(s):
Hpv 16
◽
Keyword(s):
1998 ◽
Vol 31
(2)
◽
pp. 479A
◽